Abstract:BACKGROUND: Several studies have suggested that laryngopharyngeal reflux disease (LPRD) or gastroesophageal reflux disease (GERD) is an independent risk factor for laryngeal carcinoma. However, it remains unclear whether either condition affects the level of H+/K+-ATPase expression in laryngeal carcinoma.MATERIALS AND METHODS: Immunohistochemistry, real-time RT-PCR, and Western blotting were used to explore the distributions of proton pump (H+/K+-ATPase) α- and β-subunits in normal laryngeal tissue and laryngeal carcinoma.RESULTS: Messenger RNAs encoding both the α- and β-subunits were found in the normal epiglottic, ventricular fold, vocal fold, and arytenoid mucosae, as well as epiglottic cartilage. The distributions and expression levels of H+/K+-ATPase α-subunits in various laryngeal subregions did not significantly differ in IHC, RT-PCR, or Western blotting. However, Western blotting revealed a significant difference between the expression level of the β-subunit protein in the epiglottic cartilage and the levels in other sites. The expression levels of both subunits were significantly higher in carcinomatous than in paracarcinomatous tissue and normal laryngeal tissue. The mean follow-up duration was 66.2 months (range, 17-162 months). In all, 4 patients died during follow-up, 4 were lost to follow-up, and 22 were alive and free of disease at the end of follow-up. Two patients developed lung metastases and six developed disease recurrences (at 2, 8, 14, 16, 36, and 41 months). The 3- and 5-year overall survival (OS) rates were 93.0% and 77.0%, respectively. Univariate analyses showed that the 5-year OSs were significantly associated with the T, N, and clinical stages but not with age, alcohol use, pathological differentiation, or the expression levels of the α- or β-subunits (as revealed by IHC, RT-PCR, or Western blotting). However, in multivariate regression analyses, the 5-year OSs were not significantly associated with any clinicopathological factor or the expression levels of either subunit.CONCLUSION: H+/K+-ATPase is expressed in the normal larynx, including in the epiglottic cartilage and the mucosae of the epiglottis, ventricular fold, and arytenoid vocal fold. The expression levels of the H+/K+-ATPase α- and β-subunits in laryngeal carcinomas were higher than in normal laryngeal tissues.

Pump Proton and Laryngeal H<SUP>+</SUP>/K<SUP>+</SUP> ATPases

Acidified Pepsin Promotes Laryngeal Precancerosis by Upregulating H+/K+-ATPase and Activating Mitophagy in Laryngeal Epithelial Cells

H+/K+-ATPase inhibitors: a patent review.

The Role of Glut-1 and H+/K+-ATPase Expression in Hyperplasia of Mice Laryngeal Epithelium Induced by Pepsin

Gastric H + /K + -ATPase Expression in Normal Laryngeal Tissue and Laryngeal Carcinoma

Gastric Adenosine Triphosphatases: A Review of Their Possible Role in HCL Secretion

Gastroesophageal Reflux Disease and Reflux Laryngopharyngitis

ATP12A Proton Pump as an Emerging Therapeutic Target in Cystic Fibrosis and Other Respiratory Diseases

The Role of ATP in Cough Hypersensitivity Syndrome: New Targets for Treatment

Evaluation and Management of Laryngopharyngeal Reflux Disease: State of the Art Review

THE FUNCTIONAL ROLE OF K+‐ATPASE IN PROTON TRANSPORT BY GASTRIC MICROSOMAL VESICLES

The Meta-analysis for the Effects of Proton Pump Inhibitors on the Treatment of Gastroesophageal Reflux Laryngitis

Laryngopharyngeal reflux disease: Updated examination of mechanisms, pathophysiology, treatment, and association with gastroesophageal reflux disease

Diagnosis of Laryngopharyngeal Reflux: Past, Present, and Future—A Mini-Review

Bioinformatic Study of Possible Acute Regulation of Acid Secretion in the Stomach

The treatment efficacy of adding prokinetics to PPIs for gastroesophageal reflux disease: a meta-analysis

Pepsin Increases the Proliferation of Vocal Cord Leukoplakia Epithelial Cells by Inducing Autophagy

Effects of Proton Pump Inhibitor Therapy for Laryngopharyngeal Reflux on Posttreatment Symptoms and Hypopharyngeal pH

Role and mechanism of Glut-1 and H+/K+-ATPase expression in pepsin-induced development of vocal cord leukoplakia

Protonated Form: the Potent Form of Potassium-Competitive Acid Blockers.

Potassium-competitive acid blockers: rethinking acid suppression for gastroesophageal reflux disease and Helicobacter pylori